Phio Pharmaceuticals Corp.

PHIO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$7-$11-$11-$13
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$1-$1$1
Other Non-Cash-$0$0$0$0
Operating Cash Flow-$7-$11-$12-$12
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$0-$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$4$7$0$20
Stock Repurch.-$0-$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$0$2
Financing Cash Flow$4$7-$0$22
Forex Effect$0$0$0$0
Net Chg. in Cash-$3-$3-$12$10
Supplemental Information
Beg. Cash$8$12$24$14
End Cash$5$8$12$24
Free Cash Flow-$7-$11-$12-$12
Phio Pharmaceuticals Corp. (PHIO) Financial Statements & Key Stats | AlphaPilot